These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy. Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370 [TBL] [Abstract][Full Text] [Related]
5. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography. Bonini Filho MA; de Carlo TE; Ferrara D; Adhi M; Baumal CR; Witkin AJ; Reichel E; Duker JS; Waheed NK JAMA Ophthalmol; 2015 Aug; 133(8):899-906. PubMed ID: 25996386 [TBL] [Abstract][Full Text] [Related]
6. Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation. Ho M; Li G; Mak A; Ng D; Iu L; Lai F J Ophthalmol; 2021; 2021():9929864. PubMed ID: 34350034 [TBL] [Abstract][Full Text] [Related]
7. The overlapping spectrum of flat irregular pigment epithelial detachment investigated by optical coherence tomography angiography. Pichi F; Morara M; Veronese C; Ciardella AP Int Ophthalmol; 2018 Jun; 38(3):975-983. PubMed ID: 28497336 [TBL] [Abstract][Full Text] [Related]
13. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy. Shin YU; Lee BR Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695 [TBL] [Abstract][Full Text] [Related]
14. [OCT-morphometric and angiographic parallels between different variants of central serous chorioretinopathy]. Panova IE; Shaimov TB; Shaimova VA Vestn Oftalmol; 2017; 133(2):10-17. PubMed ID: 28524134 [TBL] [Abstract][Full Text] [Related]
15. Change in choroidal vascularity in acute central serous chorioretinopathy. Rasheed MA; Goud A; Mohamed A; Vupparaboina KK; Chhablani J Indian J Ophthalmol; 2018 Apr; 66(4):530-534. PubMed ID: 29582814 [TBL] [Abstract][Full Text] [Related]
16. Central Serous Chorioretinopathy: An Update on the Current State of Management. Kalogeropoulos D; Shaw L; Skondra D; Ch'ng SW; Christodoulou A; Kalogeropoulos C Klin Monbl Augenheilkd; 2024 Jul; 241(7):845-862. PubMed ID: 37336237 [TBL] [Abstract][Full Text] [Related]
17. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy. Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738 [TBL] [Abstract][Full Text] [Related]
18. The noninvasive predictive approach for choroidal vascular diffuse hyperpermeability in central serous chorioretinopathy: near-infrared reflectance and enhanced depth imaging. Hua R; Liu L; Chen L Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):365-71. PubMed ID: 25046401 [TBL] [Abstract][Full Text] [Related]
19. The hyper-fluorescent transitional bands in ultra-late phase of indocyanine green angiography in chronic central serous chorioretinopathy. Hua R; Yao K; Xia F; Li J; Guo L; Yang G; Tao J Lasers Surg Med; 2016 Mar; 48(3):260-3. PubMed ID: 26482206 [TBL] [Abstract][Full Text] [Related]
20. Predicting visual outcomes for macular disease using optical coherence tomography. Keane PA; Sadda SR Saudi J Ophthalmol; 2011 Apr; 25(2):145-58. PubMed ID: 23960916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]